Pinnacle Wealth Planning Services Inc. lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 31.8% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 4,135 shares of the healthcare conglomerate’s stock after selling 1,932 shares during the period. Pinnacle Wealth Planning Services Inc.’s holdings in UnitedHealth Group were worth $2,091,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also bought and sold shares of the stock. State Street Corp raised its holdings in UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after acquiring an additional 563,554 shares in the last quarter. Geode Capital Management LLC increased its position in UnitedHealth Group by 1.6% during the third quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock worth $11,440,133,000 after buying an additional 318,039 shares during the last quarter. Franklin Resources Inc. increased its position in UnitedHealth Group by 2.5% during the third quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after buying an additional 193,800 shares during the last quarter. Bank of New York Mellon Corp increased its position in UnitedHealth Group by 0.5% during the fourth quarter. Bank of New York Mellon Corp now owns 7,931,478 shares of the healthcare conglomerate’s stock worth $4,012,218,000 after buying an additional 36,394 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in UnitedHealth Group by 3.0% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 6,223,331 shares of the healthcare conglomerate’s stock worth $3,148,134,000 after buying an additional 182,361 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts have weighed in on UNH shares. Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Wells Fargo & Company decreased their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Truist Financial decreased their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Finally, Stephens upped their target price on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $629.32.
UnitedHealth Group Stock Up 0.3 %
NYSE UNH opened at $476.22 on Thursday. The business has a fifty day moving average price of $514.58 and a two-hundred day moving average price of $554.81. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a market capitalization of $438.25 billion, a PE ratio of 30.72, a PEG ratio of 1.37 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the prior year, the company earned $5.83 earnings per share. The company’s quarterly revenue was up 6.8% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.76%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.
Insider Activity
In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is owned by corporate insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
- Five stocks we like better than UnitedHealth Group
- Using the MarketBeat Stock Split Calculator
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- How to Profit From Growth Investing
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Learn Technical Analysis Skills to Master the Stock Market
- Is Advanced Micro Devices Stock Slide Over?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.